- Home
- AMPY vs PRQR Comparison
AMPY vs PRQR Comparison
Compare AMPY & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- PRQR
- Stock Information
- Founded
- AMPY 2011
- PRQR 2012
- Country
- AMPY United States
- PRQR Netherlands
- Employees
- AMPY N/A
- PRQR N/A
- Industry
- AMPY Oil & Gas Production
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- PRQR Health Care
- Exchange
- AMPY Nasdaq
- PRQR Nasdaq
- Market Cap
- AMPY 265.7M
- PRQR 309.5M
- IPO Year
- AMPY 2011
- PRQR 2014
- Fundamental
- Price
- AMPY $5.76
- PRQR $2.69
- Analyst Decision
- AMPY Strong Buy
- PRQR Strong Buy
- Analyst Count
- AMPY 3
- PRQR 5
- Target Price
- AMPY $10.00
- PRQR $7.60
- AVG Volume (30 Days)
- AMPY 241.3K
- PRQR 625.1K
- Earning Date
- AMPY 11-06-2024
- PRQR 11-07-2024
- Dividend Yield
- AMPY N/A
- PRQR N/A
- EPS Growth
- AMPY N/A
- PRQR N/A
- EPS
- AMPY 1.55
- PRQR N/A
- Revenue
- AMPY $304,645,000.00
- PRQR $20,506,357.00
- Revenue This Year
- AMPY $8.94
- PRQR $235.11
- Revenue Next Year
- AMPY N/A
- PRQR N/A
- P/E Ratio
- AMPY $3.69
- PRQR N/A
- Revenue Growth
- AMPY 17.42
- PRQR 306.68
- 52 Week Low
- AMPY $3.56
- PRQR $1.61
- 52 Week High
- AMPY $8.15
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- AMPY 30.59
- PRQR 34.92
- Support Level
- AMPY $5.76
- PRQR $2.48
- Resistance Level
- AMPY $6.18
- PRQR $3.46
- Average True Range (ATR)
- AMPY 0.18
- PRQR 0.28
- MACD
- AMPY -0.06
- PRQR -0.12
- Stochastic Oscillator
- AMPY 8.08
- PRQR 18.72
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana, and Eagle Ford.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.